Loading...
Sugi Holdings Co.,Ltd.
SGIPF•PNK
Healthcare
Medical - Pharmaceuticals
$16.29
$0.00(0.00%)
Sugi Holdings Co.,Ltd. (SGIPF) Financial Performance & Income Statement Overview
Review Sugi Holdings Co.,Ltd.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
17.94%
↑ 17.94%
Operating Income Growth
16.22%
↑ 16.22%
Net Income Growth
16.88%
↑ 16.88%
Operating Cash Flow Growth
-5.38%
↓ 5.38%
Operating Margin
4.85%
↑ 4.85%
Gross Margin
31.33%
↑ 31.33%
Net Profit Margin
2.93%
↑ 2.93%
ROE
10.53%
↑ 10.53%
ROIC
15.25%
↑ 15.25%
Sugi Holdings Co.,Ltd. (SGIPF) Income Statement & Financial Overview
Review Sugi Holdings Co.,Ltd.'s (SGIPF) income statement with detailed quarterly and annual figures.
Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
---|---|---|---|---|
Revenue | $243.40B | $220.81B | $212.85B | $200.96B |
Cost of Revenue | $163.80B | $151.10B | $147.11B | $140.97B |
Gross Profit | $79.60B | $69.71B | $65.74B | $59.99B |
Gross Profit Ratio | $0.33 | $0.32 | $0.31 | $0.30 |
R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
SG&A Expenses | $65.79B | $61.25B | $54.06B | $51.38B |
Operating Expenses | $65.79B | $61.25B | $54.06B | $51.38B |
Total Costs & Expenses | $229.59B | $212.35B | $201.17B | $192.35B |
Interest Income | $211.00M | $0.00 | $0.00 | $0.00 |
Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
Depreciation & Amortization | $5.09B | $3.53B | $3.88B | $3.75B |
EBITDA | $17.93B | $11.99B | $15.56B | $8.61B |
EBITDA Ratio | $0.07 | $0.05 | $0.07 | $0.04 |
Operating Income | $13.81B | $8.46B | $11.68B | $8.61B |
Operating Income Ratio | $0.06 | $0.04 | $0.05 | $0.04 |
Other Income/Expenses (Net) | -$4.17B | $388.00M | -$1.34B | $644.00M |
Income Before Tax | $9.64B | $8.85B | $10.34B | $9.25B |
Income Before Tax Ratio | $0.04 | $0.04 | $0.05 | $0.05 |
Income Tax Expense | $3.009B | $2.85B | $3.40B | $3.13B |
Net Income | $6.63B | $6.00B | $6.94B | $6.12B |
Net Income Ratio | $0.03 | $0.03 | $0.03 | $0.03 |
EPS | $36.65 | $33.14 | $38.33 | $33.84 |
Diluted EPS | $36.65 | $33.14 | $38.33 | $33.84 |
Weighted Avg Shares Outstanding | $180.97M | $180.97M | $180.97M | $180.96M |
Weighted Avg Shares Outstanding (Diluted) | $180.97M | $180.97M | $180.97M | $180.96M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan